Review and publication of protocol submissions to Trials – what have we learned in 10 years?

Trials has 10 years of experience in providing open access publication of protocols for randomised controlled trials. In this editorial, the senior editors and editors-in-chief of Trials discuss editorial issues regarding managing trial protocol submissions, including the content and format of the protocol, timing of submission, approaches to tracking protocol amendments, and the purpose of peer reviewing a protocol submission. With the clarification and guidance provided, we hope we can make the process of publishing trial protocols more efficient and useful to trial investigators and readers.

[1]  Ida Sim,et al.  Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1) , 2005, BMJ : British Medical Journal.

[2]  Richard Horton,et al.  Pardonable revisions and protocol reviews , 1997, The Lancet.

[3]  S. Evans,et al.  Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet , 2008, The Lancet.

[4]  J. Siegel.  Editorial review of protocols for clinical trials. , 1990, The New England journal of medicine.

[5]  B. Djulbegovic,et al.  Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols. , 2012, Journal of clinical epidemiology.

[6]  Douglas G Altman,et al.  Comparison of protocols and registry entries to published reports for randomised controlled trials. , 2011, The Cochrane database of systematic reviews.

[7]  H. Poulsen,et al.  From protocol to published report: a study of consistency in the reporting of academic drug trials , 2016, Trials.

[8]  Harlan M Krumholz,et al.  Increasing value and reducing waste: addressing inaccessible research , 2014, The Lancet.

[9]  A. Hrõbjartsson,et al.  Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study , 2005, BMJ : British Medical Journal.

[10]  D. Moher,et al.  Protocols, probity, and publication , 2009, The Lancet.

[11]  J. Kempen,et al.  Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial – lessons for comparative effectiveness trials , 2011, Clinical trials.

[12]  A. Hrõbjartsson,et al.  Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory. , 2009, Journal of clinical epidemiology.

[13]  J. Kempen,et al.  The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. , 2010, American journal of ophthalmology.

[14]  David Moher,et al.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials , 2013, BMJ.

[15]  D. Berry,et al.  From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Kent Johnson,et al.  The power of the protocol , 2002, The Lancet.

[17]  D. Rennie,et al.  SPIRIT 2013 statement: defining standard protocol items for clinical trials. , 2013, Annals of internal medicine.

[18]  J. Grimshaw,et al.  Lead editorial: Trials – using the opportunities of electronic publishing to improve the reporting of randomised trials , 2006, Trials.

[19]  Douglas G Altman,et al.  Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols , 2008, BMJ : British Medical Journal.

[20]  K. Abbasi,et al.  Trial protocols at the BMJ , 2004, BMJ : British Medical Journal.

[21]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[22]  G. Rücker,et al.  Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles , 2011, BMJ : British Medical Journal.

[23]  Alexander Foss,et al.  Major journals should peer review trials at protocol stage , 1997, BMJ.

[24]  Francis S. Collins,et al.  Toward a New Era of Trust and Transparency in Clinical Trials. , 2016, JAMA.

[25]  Tony Tse,et al.  Trial Reporting in ClinicalTrials.gov - The Final Rule. , 2016, The New England journal of medicine.

[26]  A. Colevas,et al.  Adverse event reporting in publications compared with sponsor database for cancer clinical trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.